Halozyme Therapeutics is a startup based in the United States, 1 tracked investor.
Based in the United States, Halozyme Therapeutics is a startup. Brouky records 1 investor associated with the company.
Halozyme Therapeutics develops drug delivery technologies that improve the administration and effectiveness of therapeutics to enhance patient outcomes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.